Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wellnex LifeLSE:WNX 31 3-1 Month Momentum % is -40.91% as of Aug. 08, 2026. GuruFocus rates LSE:WNX with a GF Score™ of 31/100 and a GF Value™ of £0.24 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 2,039 Consumer Packaged Goods companies, Wellnex Life ranks worse than 93.92% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-08), Wellnex Life's 3-1 Month Momentum % is -40.91%.
The industry rank for Wellnex Life's 3-1 Month Momentum % or its related term are showing as below:
LSE:WNX's 3-1 Month Momentum % is ranked worse than 93.92% of 2039
companies
in the Consumer Packaged Goods industry
Industry Median: -4.41
vs LSE:WNX: -40.91
Wellnex Life (LSE:WNX) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Wellnex Life 3-1 Month Momentum % Related Terms
LSE:WNX vs KHC, GIS: 3-1 Month Momentum % Comparison
For the Packaged Foods subindustry, Wellnex Life's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wellnex Life 3-1 Month Momentum % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Wellnex Life's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Wellnex Life's 3-1 Month Momentum % falls into.
Wellnex Life (LSE:WNX) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wellnex Life (LSE:WNX) has a 3-1 Month Momentum % of -40.91% as of Aug. 08, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Wellnex Life and its competitors. According to the industry distribution chart, Wellnex Life ranks #1915 out of 2039 companies in the Consumer Packaged Goods industry, placing it in the top 93.9%.
Is Wellnex Life's 3-1 Month Momentum % too high?
Wellnex Life's current 3-1 Month Momentum % is -40.91%. Based on the distribution chart, Wellnex Life ranks #1915 out of 2039 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Wellnex Life has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Wellnex Life's 3-1 Month Momentum % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Wellnex Life ranks #1915 out of 2039 companies for 3-1 Month Momentum %. This places Wellnex Life in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Consumer Packaged Goods company?
A good 3-1 Month Momentum % depends on the Consumer Packaged Goods industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Wellnex Life and its competitors. Wellnex Life's current 3-1 Month Momentum % is -40.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellnex Life stock overvalued right now?
Based on GuruFocus' analysis, Wellnex Life (LSE:WNX) is currently considered Possible Value Trap. The stock's GF Value™ is £0.24, compared to a current price of £0.06 — trading 77.1% below its estimated fair value. The current 3-1 Month Momentum % is -40.91%. Wellnex Life's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Wellnex Life (LSE:WNX), the current 3-1 Month Momentum % is -40.91% as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wellnex Life (LSE:WNX) Overvalued in 2026?
Based on GuruFocus' analysis, Wellnex Life stock appears to be undervalued.
The current stock price of £0.06 is trading 77.1% below its estimated GF Value™ of £0.24.
GuruFocus considers Wellnex Life to be Possible Value Trap.
Key valuation signals for LSE:WNX:
3-1 Month Momentum %: -40.91%
GF Value™: £0.24 vs. price of £0.06 (77.1% below fair value)
No single metric tells the full story. See the LSE:WNX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wellnex Life Ltd is a consumer healthcare company focused on developing, licensing, marketing, and distributing healthcare and pharmaceutical products. These products are available mainly through Australian retailers and wholesalers, including Coles, Woolworths, Chemist Warehouse, Sigma, and Symbion. The group's offerings include caffeine energy liquid capsules, multivitamins, pain relief creams and sprays, sleep aids, toothpaste, over-the-counter medicines, and medical cannabis products, among others. Its brands include Pharmacy Own, Wellness Life, Mr. Bright, Pain Away, Nighty Night, Wakey Wakey, and Wagner Health Liquigesic. Geographically, the majority of the group's revenue comes from Australia, with additional contributions from the United Kingdom and New Zealand.
31GF Score
Get the complete analysis for LSE:WNX
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:WNX has been successfully added to your 
